Transdermal Estrogen in Women With Anorexia Nervosa

Recruiting Phase 2 Interventional Study
Anorexia Nervosa
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 – 45
Sex
Female
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
66 (estimated)
Sponsor
Pouneh K. Fazeli, MD · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Randomized, placebo-controlled study investigating the use of physiologic, transdermal estrogen for low bone mass in adult women with anorexia nervosa.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Female 2. 19-45 years of age 3. DSM-5 psychiatric criteria for anorexia nervosa 4. \<85% of ideal body weight as defined by the 1983 Metropolitan Life Insurance Height and Weight Tables 5. Amenorrhea 6. T-score of \< -1.0 at spine or hip Exclusion Criteria: 1. Diseases know…
Contacts

Pouneh Fazeli, MD

412-586-9700

pkfazeli@pitt.edu

CONTACT

Shari Reynolds

CONTACT